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Peptide and polypeptide hormones represent an extensive group of biologically 
active compounds of important significance for medicine and agriculture. In 
recent years genetic engineering methods have been used to create strains of 
microorganisms synthesizing eukaryotic proteins, including hormones and their 
precursors. The first stage of such developments is the isolation of DNA cod-
ing the des~red product. We have accomplished the cloning of the cDNA of a 
number of polypeptide and peptide hormones of the pituitary of man and domes-
tic animals. The model gene of human calcitonin has also been synthesized and 
cloned. The obtained genes are being used to develop methods for the micro-
biological synthesis of human and animal-hormones. 
One of the new possibilities opened by the development of genetic engineering is the 
production of strains of microorganisms programmed for the synthesis of polypeptides of great 
practical significance. The genetic-engineering production of polypeptides is a practical 
problem but also greatly expands the potential for basic research, since the construction of 
systems of expression of foreign genes in pro- and eukaryotic cells and the comparison of 
their effectiveness permits a more through analysis of the mechanisms of gene function and 
regulation. Among the products of great interest f~om a practical viewpoint are many pep-
tides and polypeptide hormones. It is not surprising that the first studies of the expres-
sion of foreign genes in Esche~iahia coZi were devoted to the synthesis of such hormones as 
somatostatin [1], growth hormone [2J, insulin [3], and others [4]. 
The Laboratory of Functional Enzymology, Institute of Molecular Biology, Academy of 
Sciences of the USSR, has for a number of years conducted studies of the cloning and expres-
sion in heterologous systems of the genes of polypeptide and peptide hormones. The present 
article will describe some of the results of these investigations. 
The successful realization of a .project for the genetic-engineering production of a 
needed peptide or polypeptides requires the solution of a whole series of problems [5). The 
first stage is the production of DNA coding of the intact product. There are twO means for 
solving this problem: The isolation of a natural DNA fragment or the chemicoenzymatic t'on 
synthesis of polydeoxynucleotide. In the first case the method of reverse rnRNA transcrip ~ i f rma-is generally used, resulting in the production of a DNA fragment containing complete n 0 
tion on the polypeptide structure. The chemicoenzymatic method permits the synthesis of an s-
artificial sequence of nucleotides. Being more laborious, this approach at the same ~ime. po 
sesses the advantage that it permits the introduction of various changes into the cod~ng 
sequence. The experimentor can thus vary the structure of the obtained product, creating 
analogs of the natural polypeptide or peptide. 
Institute of Molecular Biology, Academy of Sciences of the USSR, MoscoW. Translated 
from Moleku1yarnaya Bio1ogiya, Vol. 19, No. 1, pp. 267-277, January-February, 1985.  
 
226   
ori 
,_ a 
ori 
b 
F~g. 1. Schem: of organization of plasmid vectors ensuring 
d~rect express10n (a) and expression of hybrid protein (b). 
P) Promotor; SD) Shine-Dalgarno sequence; ATG) initiating cod-
on; Stop) terminating codon; Ori) replication initiation site' 
Ar) antibiotic resistance gene. Region occupied by nucleotid~ 
sequence coding desired product is hatched. 
The next problem is to ensure the expression of the cloned gene in the cell. There are 
two approaches to solving this problem. The first is the synthesis of a hybrid protein and 
the subsequent excision from it of the necessary polypeptide; the second is the direct ex-
pression of this polypeptide. The first technique ~as first used to obtain the hormone 
somatostatin [lJ; it is usually used for the synthesis of short peptides that are rapidly de-
graded in microorganismic cells. The second method is used in the microbiological synthesis 
of polypeptides that are stable within the cell. 
Figure 1 presents schematically the organization of vectors ensuring the expression of 
hybrid proteins and the direct expression of foreign po1ypeptides in bacterial cells [5]. As 
apparent from the scheme, during direct expression the gene is placed under the control of 
the bacterial promotor; inserted in front of the initiating codon is a region providing for 
translation initiation (SD, the Shine-Dalgarno sequence). For the expression of the hybrid 
protein the sequence coding the desired product is attached (with the preservation of the 
read frame) to the gene for any buffer protein. The S-galactosidase gene is most frequently 
used for this in the case of E. ooZi [1, 6-10]. At the same time, the initiation of trans-
cription and translation is ensured by the signal elements of the, bacterial gene. 
The last stage, of development is the isolation of the synthetic product from the cell, 
its purification and characterization. In general, the development of methods for the micro-
biological synthesis of valuable polypeptides is a complex problem, requiring the use of mod-
ern methods of molecular biology and genetics, biochemistry, bioorganic chemistry, micro-
biology, and other related disciplines. The present article will illustrate the separate 
stages of this approach for the production of certain peptide and polypeptide hormones as 
exemplified by studies at the Laboratory. 
Cloning of cDNA of Polypeptide and Peptide Hormones. A universal means for obtaining 
DNA coding of one or another polypeptide is the method of cloning cDNA synthesized on the 
mRNA of the given polypeptide. A decisive role in the success of cloning is played by the 
selection of the source from which the mRNA is isolated. Enriched mRNA preparations Can be 
obtained by the use for mRNA isolation of specialized tissues or tumors producing increased 
quantities of the desired product. The synthesis of DNA complementary to this mRNA and its 
cloning permit the creation of banks of clones enriched with the necessary sequences. This 
approach was used in our laboratory to construct clone banks containing DNAs complementary to 
the template RNAs of human and domestic-animal pituitaries. The guanidine thiocyanate meth-
od [11] was used for the isolation of mRNA from pituitaries (pituitary adenomas obtained at 
the Institute of Neurosurgery, Academy of Medical Sciences of the USSR, during the surgery 
of patients suffering acromegaly were used as the starting material); the po1y(A)-containing 
RNA fraction was isolated by chromatography on a column with oligo(dT) cellulose [12J; double-
stranded cDNA was synthesized by the standard method (13J and fractionated with the help of 
electrophoresis in polyacrylamide gel. Earlier it was shown that the complete length of the 
mRNA of mammalian growth prehormone is 800-900 nucleotides, not counting the poly(A) sequences 
(14); therefore, an additional enrichment of the mixture with full-sized cDNA copies of growth 
227 
-. , . 
-:.::'1-·' ,fr, ,- . ., ,. . 
•• ' •• • ' . if 
•• ... iI 
•• •• J. ... t •• 
.,,-: ••• : .. ,." tIf~ 
... . -,. 
t .:. -j!:_ 
.-,_ .. . ."-.*1 . • 
, · -i.: ~ .-1 
.. 
~ 
• 
• 
QC> 0, • 
•• 
fIIP<~: 
• 4\), 
• 
• 
" 
• 
'" 
.1 :> 
• .. 
• 
• 
-. 
t 
b 
•• 
Fig. 2. Hybridization 
bovine pituitary criNA. 
growth prehormone (a) 
swine pituitary cDNA. 
prehormone. 
of colonies on filter: 8. b) bank of 
Trials) cloning of cDNA of human 
and rat prolactin Cb). c) Bank of 
Trial) cloned cDNA of bovine growth 
prehonnone \.;a5 attained by e.xtracting a fraction of abollt 800 bp size from the gel. This 
fra c tio n was cloned in the HindIII region of the plasmid pBR322 using the link er technique 
[l51 . 
The next stage of the work was the isolat ion from the banks of individual cl ones co n-
taining hormone genes. A clone was first isolated containing a full-sized copy of th~ cDNA 
of human growth hormone prec ursor. This was done using the methods of hybr i dization of 
co l onLes with highly labeled cDNA (16), restrictase analysis, and the partial sequencing of 
th e i n s er tions [17]. In one plasmid detected in thls way (phGH18) the cDNA insertion con-
si st ed of 809 bp and contained a 5'-nontranslatable region (30 bp), sequences codlng a signal 
pep tide (78 bp) and mature grm>lth hormone (573 bp), a 3' -nontranslatable region (l08 bp), and 
a po ly(dA) sequence (20 bp). The primary structure of the cDNA we cloned was indi.stinguish-
ab le from that published earlier [18]. 
An analysis of the banks containing insertions of the cDNA of domestj.c-animal pituitaries 
by hybridiza t ion of the co lonies with labeled cloned cDNA made it possible to detect clones 
bearing p l asmids wi t h ins er t i ons of the cDNA of bovine and swine growth prehormones (Fig . 28, 
c) . T11P. pl asmid pbGH1 8 , contain ing an insertion of bovine growth pre hormone cDNA of abou ~ 
830 bp si ze , was invest i gated in de tail using restrictase analysis and subsequent sequenc l n g 
(Figs . lb and 4). The insert i on from this plasmid included 33 bp of the S'-nontra!lslata ble 
reg i on , 6 51 bp of the prehormone-coding sequence, 104 bp of the 3 f -nontranslatable region, 
a nd a poly(dA) sequence. The cloned cDNA of bovine growth prehormone from plasmid pbGH18 had 
four substitutions in the coding part and an insertion of two base pairs in the 5'-00ntrans-
latable region compared with the nucleotide sequence published by Mill~r et a1. (19). All 
s ubs titutions in the coding region were in the third position of the codons and did not in-
fl uence the amino acid sequences of the hormone. 
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Fig. 3. Autoradiograms of struc-
tural gels obtained after the 
sequencing of the cloned cDNAs of 
human (a) and bovine (b) growth 
prehormones. 
Also isola t ed from the bank of pi tui tary cDNA clones was tbe plasmid pbL Tl9, conts ining 
the cDNA of the precursor of the adrenocorticotropic hormone (ACTH) and a-lipoprotein. 111e 
cloned cDNA, as demonstrated by the determination of its complete nucleotide sequence (Figs. 
5 and 6)) represents an incomplete copy of the mRNA coding the polypeptide precursor of ACTH 
and S-lipoprotein. The first 47 base pairs of the insertion represent the result of a re-
organization that probably occurred during cloning; nevertheless, the plasmid pbLT19 con-
tains sequences coding all known pepticles formed from the fnUisl polypeptide precursor. 
Also isolated from the obtained banks of agricultural-animal clones were plasmids with 
inse rtions of prolactin-precursor DNA (Fig. 2b). Thus t the cloning of cDNA i.s a sufficient-
l y effective means of obtaining starting material for the subsequent construction of recom-
binant plasmids ensuring hormone expression in microorganismic cells. 
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Fig. 4. a) Nucleotide sequenc hf cloned cDNA and amino acid 
sequence of bovine growth prehor:n01'18 derive •. : from it. Differ-
ences compared with published sequence [19] indicated. b) Re-
stri.ctase map of insertion from plasmid pbG1U8. Arrow shows 
orientation of insertion. Sequence coding signal peptide is 
hatched; sequence coding mature hormone is darkened. 
,~~:!.1! ':12j(:(~~~:'I2:Y..:.r'_'~ ~~'::._.:~1:12!:t!_~...:~:..S of Pep~.!.9~_::-_Hormone Genes. An alternative means ~f obta~n­
i.ng DNA fragments coding the required product is the chemicoenzymatic synthesis ot polyde-
oxynucleotides, the strategy of which was developed by Khorana's group in the late 1960s [20. 
2:l}. At the present tLme the phosphotriester method is the most widely used for the synth-
esis of ol:i.godeoxynucleotides (22). In our laboratory thi.:;; method was used for the synthesis 
of a model gene of human calci.tonin - a thyroid gland' peptide hormone consistj,ng of 32 amino 
acid residues [231 and regulating calci.um metabolism 1.n the organism [241. Taken as ~ basi~ 
fo r plann1.ng the synthesis of the gene was the natural nucleotide sequence published 10 1~8-
[25J. The following changes were introduced into this sequence: 1) The triplet ATG, codlng 
methioni.ne-8) was substituted by the valine codon, GTT; 2) the point substitutions of G for 
T and C for A were made in positions 38 and 41. respectively, of the nucleotide sequence 
(Fig . 7). Methionine was substituted by valine so that the whole product might be isolated cl 
from hybrid proteins by means of their treatment with cyanobromide. This substitution shoul 
not affect the immunologic properties and b1.ological activity of calcitonin, since according 
to the current c01'lc.epts of the structural organization of this hormone its active part is 
the fragment 10-32 (26). Point substitutions in the 38th and 41st po.sitions of the nucleo-
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Fig. 5. Autoradiogram of structural 
gel obtained during the sequencing of 
cloned cDNA of ACTH--!3-Hpotropin pre-
cursor. 
tide sequence , which do not alter the structure of the coded peptide, result in the appearance 
of a restrictase KpnI cleavage site (GGTACC), which greatly expands the possibilities of sub-
s equent manipulations with the aim of constructing different variants of the calcitonin gene . 
The general structure of the synthetic gene is presented in Fig. 7. It includes the 
tr~nSlatjon-initiating codon ATC, the coding nucleotide sequence, and the two terminating 
'~O<lons TGA and TAG. The ends of the genes are provided with the 5 '-protruding single-strand-
ed regions 5 t -AATT-3' and 5 t -GATe-3 t • which permits the insertion of the gene in to the vector 
at the EcoRI and BaroHI res tric tased te~~ 
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Fig. 7. Schem.e of organization ~f human-calci ton in synthetic . 
gene and its corresponding amino acid sequence. 1-16)-Initial 
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ligase splicing. . 
Fig. 8. Autoradiogram of structural gels 
obtained during the sequencing of cloned 
human-calcitonin model gene. 
In planning the synthesis, the nuele.otide sequence of the gene was broken up into 16 
~ragments (eight fragments each in the translated and complementary chains) so that the ov~r­
".ap of compleml>ntary sequences would comprise from sIx to nine nucleot i.des when the fragme .1ts 
were jOined. The enzymatic splicing of the synthetic gene from oligonucleotide fragments 
synthesized by the block triester method in solution [27] with certain modifications was per-
formed in several stages. Chains I-IV wer.e first assembled (Fig. 7), which, afte.T isolation 
I' 
.rom the incubation mixtures and verification of their nucleot~de sequence. were spliced to 
obtain the synthetic model gene of human calcitonin. The structure of the. complete gene was 
verified by the Haxam-Gilbert method [17]. We cloned the synthetic human-calcitonin model 
gene in the vector pBR322 (Fig. 8) and will use it in the Laboratory's subsequent studies. 
Expression of Growth Hormone Gene in E. coZi Cells and Characterization of Product. The 
nexts-tage in the -isoiation of poiypeptides by genei:ic-engineeri~gmethods isthe--ex-pression 
of the gene in the recipient cell and the isolation and characterization of the synthesized 
product. One of the first polypeptide products obtained by genetic-engineering is human 
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growth hormone. The firm Genentech Inc. (USA) has synthesized a "quasisynthetic" hormone 
gene consisting of an artificial DNA sequence coding 23 amino acid residues of the N-terminal 
part of the hormone and a cDNA fragment bearing information on the rest of the molecule [2]. 
The introduction in front of the gene of a DNA fragment containing the lac UV5 promotor and 
the translation initiation signal of the lac Z gene of E. coU ensured the effective expres-
sion of the gene and resulted in the synthesis of hormone in a quantity reaching 185,000 
molecules per cell [2]. Later, the method of the direct expression of polypeptides in E. 
coLi was used to obtain many proteins important in medicine and agriculture, such as inter-
ferons [28-30], blood proteins [31], enzymes [32], etc. 
We have employed this method to construct E. coLi strains to produce human growth hor-
mone. Using as the starting material the cloned cDNA of human gro~.,th prehormone, ,.;re removed 
from it the 5'-nontranslatable region and the sequence coding the signal peptide and intro-
duced in its place a translation initiation codon. The reconstructed human grmvth hormone 
gene that was obtained was placed in E. coli under the control of various promotors. The E. 
coZi strains transformed by such p1asmids synthesized human growth hormone, as demonstrated 
by double radial immunodiffusion in agar. The highest level of synthesis comprised (by an 
approximate estimate) more than 550,000 molecules per cell. 
An analysis was also made of the physicochemical and biological properties of the hor-
mone synthesized in the cells of the producer strain. Growth hormone was extracted from the 
biomass following described schemes [2, 33, 34]. The investigation of a highly purified hor-
mone preparation showed that it is identical to hormone extracted from cadaver pituitaries 
according to data electrophoresis in denaturing polyacrylamide gel, gel filtration on Sephadex 
G-lOO, double radial immunodiffusion, and the biological determination of activity using the 
tibia test [35]. 
Human growth hormone is one of the key hormones regulating various aspects of metabolism. 
It possesses fat-mobilizing, renotropic, and lactogenic activities, acts on carbohydrate and 
mineral metabolims, and increases tissue regeneration [36, 37]. Because of the shortage of 
growth hormone preparation, it is used in medicine only to treat pituitary dwarfism caused 
by a disturbance of pituitary hormone biosynthesis. Data are available on the positive ef-
fect of growth hormone in the treatment of complex fractures, burns, and ulcers [37J. The 
development of methods for the genetic engineering of strains producing human growth hormone 
opens prospects for the increased production of the medical preparation of this hormone and 
its clinical use. 
The cloning of growth-hormone cDNA from agricultural animals performed in the Laboratory 
is an important step toward the production of these compounds by means of microbiological 
synthesis. 
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